Oppenheimer & Co. Inc. lessened its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 1.8% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 111,836 shares of the company’s stock after selling 2,024 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $1,666,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Estabrook Capital Management bought a new position in BlackRock Health Sciences Term Trust during the fourth quarter valued at approximately $35,000. Elequin Capital LP bought a new position in BlackRock Health Sciences Term Trust during the fourth quarter valued at approximately $84,000. Yakira Capital Management Inc. bought a new position in BlackRock Health Sciences Term Trust during the fourth quarter valued at approximately $153,000. Virtu Financial LLC bought a new position in BlackRock Health Sciences Term Trust during the fourth quarter valued at approximately $206,000. Finally, K2 Principal Fund L.P. raised its position in BlackRock Health Sciences Term Trust by 62.7% during the fourth quarter. K2 Principal Fund L.P. now owns 16,271 shares of the company’s stock valued at $234,000 after acquiring an additional 6,271 shares in the last quarter.
BlackRock Health Sciences Term Trust Stock Up 0.3%
Shares of BMEZ opened at $14.40 on Friday. BlackRock Health Sciences Term Trust has a twelve month low of $12.58 and a twelve month high of $16.75. The firm’s 50 day moving average price is $14.38 and its 200 day moving average price is $14.93.
BlackRock Health Sciences Term Trust Cuts Dividend
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- What Are the U.K. Market Holidays? How to Invest and Trade
- EA Just Caught a Monster Upgrade: Bullish Breakout Ahead?
- CD Calculator: Certificate of Deposit Calculator
- 3 Stocks Hitting All-Time Highs With More Room to Run
- 10 Best Airline Stocks to Buy
- QuantumScape Soars 30%: What Drove the Next-Gen EV Stock’s Rally
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.